drugset / Trial / NCT07580755

Mesenchymal Stem Cells in the Treatment of Burn Wounds

NCT07580755 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

Burn patients were randomly divided into the low-dose stem cell gel group, the high-dose stem cell gel group, and the placebo group (with only the gel), and received the same treatment under the same conditions simultaneously.

Timeline

Start
2026-04-27
Primary completion
2027-12-31
Completion
2028-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject placenta-derived mesenchymal stem cells Cell therapy — Topical

Indications

No indication recorded.